A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation Source: Eur Respir J 2008; 31: 783-789 Year: 2008
CC and C chemokine expression in pulmonary sarcoidosis Source: Eur Respir J 2002; 20: 1206-1212 Year: 2002
IL-18 and IL-12 induce inflammatory cytokines, chemokine ligand 9 (CXCL9) and T cell infiltration in pulmonary tissue Source: Annual Congress 2011 - Lung cell injury and repair Year: 2011
Cytokine modulators as novel therapies for airway disease Source: Eur Respir J 2001; 18: 67S-77S Year: 2001
Idiopathic pulmonary fibrosis fibroblasts migrate and proliferate to CC chemokine ligand 21 Source: Eur Respir J 2007; 29: 1082-1093 Year: 2007
CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis Source: Eur Respir J 2009; 34: 676 Year: 2009
Blockade of Th1 chemokine receptors ameliorates pulmonary granulomatosis in mice Source: Eur Respir J 2011; 38: 415-424 Year: 2011
Enhanced monocyte migration to CXCR3 and CCR5 chemokines in COPD Source: Eur Respir J 2016; 47: 1093-1102 Year: 2016
Decreased levels of CXC angiogenic chemokines (IL-8, ENA-78 and GRO-α) in BALF after interferon gamma-1b treatment in IPF patients Source: Eur Respir J 2005; 26: Suppl. 49, 267s Year: 2005
Endobronchial biopsy neutrophilia, IL-8, ENA-78 and neutrophil chemokine receptor (CXCR1 and CXCR2) gene expression in severe exacerbations of asthma Source: Eur Respir J 2003; 22: Suppl. 45, 588s Year: 2003
C-C chemokine receptor 2 gene polymorphism V64I and CCR2 expression on T lymphocytes in pulmonary sarcoidosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 268s Year: 2005
The role of chemokine receptors in acute lung allograft rejection Source: Eur Respir J 2010; 35: 167-175 Year: 2010
Endobronchial biopsy neutrophilia, IL-8, ENA-78 and neutrophil chemokine receptor (CXCR1 & CXCR2) gene expression in severe exacerbations of COPD Source: Eur Respir J 2002; 20: Suppl. 38, 377s Year: 2002
Allergen challenge increases the number of airway Th2 cells expressing C-C chemokine receptors CCR4 and CCR8 Source: Eur Respir J 2001; 18: Suppl. 33, 529s Year: 2001
Small neutralizing molecules to inhibit actions of the chemokine CXCL12 and other chemokines Source: Annual Congress 2010 - Models of airways disease Year: 2010
Role of the chemokines RANTES, monocyte chemotactic proteins-3 and -4, and eotaxins-1 and -2 in childhood asthma Source: Eur Respir J 2003; 22: 310-316 Year: 2003
T cell chemokine receptor expression in COPD Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012
CCL22 and CCL17 in rat radiation pneumonitis and in human idiopathic pulmonary fibrosis Source: Eur Respir J 2004; 24: 49-56 Year: 2004
Expression of monocyte chemoattractant protein–1 (MCP-1) and CC chemokine receptor 2 (CCR2B) by purified blood monocytes in smokers with lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 318s Year: 2004
Expression of angiogenic growth factors and stromal cell derived factor-1/CXC chemokine receptor 4 (SDF-1/CXCL12 – CXCR4) biological axis in idiopathic pulmonary fibrosis: a lung tissue study Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis Year: 2008